DOI: 10.1055/s-00000125

Senologie - Zeitschrift für Mammadiagnostik und -therapie


Fasching PA, Loibl S, Hu C. et al
BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the Gepar-Quinto Study.

J Clin Oncol 2018;
36: 2281-2287 . doi:10.1200/JCO.2017.77.2285

Download Bibliographical Data

Search in: